The significance of chymase in the activation of matrix metalloproteinase-9 after myocardial infarction in hamsters

被引：0
作者：
Takai, S. [1 ]
Jin, D. [1 ]
Yoshikawa, K. [1 ]
Miyazaki, M. [1 ]
机构：
[1] Osaka Med Coll, Osaka, Japan
来源：
JOURNAL OF HYPERTENSION | 2006年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S386 / S387
页数：2
相关论文
共 50 条
[31]   Matrix Metalloproteinase-9 Stimulated Osteopontin Proteolysis Enhances the Extracellular Matrix Response Post Myocardial Infarction [J].
Bras, Lisandra E. de Castro ;
DeLeon-Pennell, Kristine Y. ;
Bratton, Dustin R. ;
Ma, Yonggang ;
Yabluchanskiy, Andriy ;
Halade, Ganesh V. ;
Lindsey, Merry L. .
CIRCULATION, 2013, 128 (22)
[32]   Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction [J].
Ducharme, A ;
Frantz, S ;
Aikawa, M ;
Rabkin, E ;
Lindsey, M ;
Rohde, LE ;
Schoen, FJ ;
Kelly, RA ;
Werb, Z ;
Libby, P ;
Lee, RT .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (01) :55-62
[33]   Usefulness of plasma matrix metalloproteinase-9 level in predicting future coronary revascularization in patients after acute myocardial infarction [J].
Wang, Ko-Fan ;
Huang, Po-Hsun ;
Chiang, Chia-Hung ;
Hsu, Chien-Yi ;
Leu, Hsin-Bang ;
Chen, Jaw-Wen ;
Lin, Shing-Jong .
CORONARY ARTERY DISEASE, 2013, 24 (01) :23-28
[34]   Usefulness of Plasma Matrix Metalloproteinase-9 Level in Predicting Future Coronary Revascularization in Patients After Acute Myocardial Infarction [J].
Wang, Ko-Fan .
CIRCULATION, 2012, 126 (21)
[35]   Association of nocturnal melatonin levels to serum matrix metalloproteinase-9 concentrations in patients with myocardial infarction [J].
Abreu-Gonzalez, P. ;
Dominguez-Rodriguez, A. ;
Garcia-Gonzalez, M. J. ;
Reiter, R. J. .
ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) :78-78
[36]   Plasma matrix metalloproteinase-9 originates from the vulnerable plaque in patients with acute myocardial infarction [J].
Higo, S ;
Nanto, S ;
Uematsu, M ;
Ohara, T ;
Kotani, JI ;
Nishio, M ;
Awata, M ;
Lida, O ;
Nagata, S ;
Yamagishi, M .
CIRCULATION, 2003, 108 (17) :415-415
[37]   Relation of nocturnal melatonin levels to serum matrix metalloproteinase-9 concentrations in patients with myocardial infarction [J].
Dominguez-Rodriguez, Alberto ;
Abreu-Gonzalez, Pedro ;
Garcia-Gonzalez, Martin J. ;
Reiter, Russel J. .
THROMBOSIS RESEARCH, 2007, 120 (03) :361-366
[38]   Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women [J].
Jefferis, Barbara J. ;
Whincup, Peter ;
Welsh, Paul ;
Wannamethee, Goya ;
Rumley, Ann ;
Lennon, Lucy ;
Thomson, Andy ;
Lawlor, Debbie ;
Carson, Claire ;
Ebrahim, Shah ;
Lowe, Gordon .
ATHEROSCLEROSIS, 2010, 208 (02) :557-563
[39]   Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study [J].
Kelly, Dominic ;
Cockerill, Gillian ;
Ng, Leong L. ;
Thompson, Matt ;
Khan, Sohail ;
Samani, Nilesh J. ;
Squire, Iain B. .
EUROPEAN HEART JOURNAL, 2007, 28 (06) :711-718
[40]   Clinical significance of matrix metalloproteinase-9 in Fragile X Syndrome [J].
Asma Laroui ;
Luc Galarneau ;
Armita Abolghasemi ;
Sérine Benachenhou ;
Rosalie Plantefève ;
Fatima Zahra Bouchouirab ;
Jean François Lepage ;
François Corbin ;
Artuela Çaku .
Scientific Reports, 12
12345